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ABSTRACT: The impact of carbapenemase production among clinically significant 
Gram-negative rods is becoming a major medical issue. To date, Acinetobacter baumannii 
has been considered as a final recipient of carbapenemase genes (imipenemase, Verona 
metallo-β-lactamase, Guiana extended-spectrum β-lactamase and Klebsiella pneumonia 
carbapenemase types) from Enterobacteriaceae and Pseudomonas aeruginosa. However, 
recent findings regarding the spread of the blaNDM carbapenemase genes revealed that 
A. baumannii likely acts as a source of emerging antibiotic resistance genes. The analysis of 
genetic structure surrounding the blaNDM-1 gene revealed that the genetic structure (Tn125) 
responsible for its dissemination most probably originates from Acinetobacter. Moreover, 
analysis of the blaNDM-1 gene itself demonstrated that it might be constructed in Acinetobacter 
through a recombination event with another resistance gene found in A. baumannii (aphA6). 
This novel paradigm highlights a novel and unexpected role played by A. baumannii.
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Members of the genus Acinetobacter seem to have the ability to quite rapidly acquire resistance to 
new antibiotics [1]. The rise of resistance to broad-spectrum antibiotics such as aminoglycosides, 
expanded-spectrum cephalosporins, carbapenems and tigecycline in Acinetobacter baumannii has 
left few therapeutic options [2]. The main problem corresponds to the rise of carbapenem resis-
tance in A. baumannii, which is almost always identiﬁed in multidrug-resistant clinical isolates 
[3]. Until now, A. baumannii has been considered a ﬁnal reservoir of antibiotic resistance genes by 
acquisition of foreign DNA from different sources, particularly from other Gram-negative species. 
Many resistance genes have been identiﬁed in A. baumannii including those encoding extended-
spectrum E-lactamases (PER-, Guiana extended-spectrum E-lactamase [GES] and VEB type) and 
aminoglycoside resistance genes [1,4]. The acquisition of those genes is often related to an integra-
tion of foreign DNA originating from other clinical species (Enterobacteriaceae and Pseudomonas 
aeruginosa) [1,2,4–7].
Carbapenem resistance in A. baumannii
Genes encoding metallo-E-lactamases of verona metallo-E-lactamase- and imipenemase types, as 
well as those encoding class A carbapenemases (Klebsiella pneumonia carbapenemase or GES), are 
other examples of acquisition of foreign resistance genes as a source of carbapenem resistance in 
A. baumannii [2]. Analysis of the genetic structures surrounding those carbapenemase genes reveals 
that they are not speciﬁc to Acinetobacter. The identiﬁed genetic structures argue for a transfer 
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from Enterobacteriaceae and P. aeruginosa to 
A. baumannii.
The most important source of carbapenem 
resistance in A. baumannii is the production 
of carbapenem-hydrolyzing Ambler class D 
E-lactamases (CHDL) [7]. Five different sub-
groups of acquired CHDLs have been identi-
ﬁed, namely oxacillinase, class D E-lactamase 
(OXA)-23, -40, -58, -143 and -235 [2,7,8]. These 
ﬁve CHDL groups are speciﬁc to the Acinetobac-
ter species and are not usually identiﬁed in other 
clinically relevant species, such as in Enterobac-
teriaceae and in P. aeruginosa [2,7]. In contrast 
to what is observed for other types of carbap-
enemase genes (those encoding the carbapen-
emases K. pneumonia carbapenemase, GES, 
verona metallo-E-lactamase and imipenemase), 
CHDL-encoding genes are associated with 
insertion sequences (IS) identiﬁed in Acineto-
bacter species (e.g., ISAba1). The natural pro-
genitor of one of these carbapenemase subgroups 
(OXA-23) has been identiﬁed as being Acineto-
bacter radioresistens [9]. To date, this corresponds 
to one of the few examples of a resistance gene 
originating from an Acinetobacter species and 
targeting another Acinetobacter species.
The case of the blaNDM genes
The bla
NDM-1
 gene is one of the latest carbapen-
emase genes to have been reported. They have 
now been extensively reported in Enterobacte-
riaceae (Escherichia coli and K. pneumoniae), ﬁrst 
from India, Pakistan and Bangladesh, and then 
from the rest of the world [10–12]. The occur-
rence of the bla
NDM-1
 gene in the environment 
has also been evidenced in India, particularly 
among environmental Gram-negative species 
[13]. Sequencing of a bla
NDM-1
-bearing plasmid, 
as part of the analysis of the resistosome of a 
multidrug-resistant E. coli, led to the identiﬁca-
tion of a remnant of ISAba125, located imme-
diately upstream of the bla
NDM-1
 gene [14]. The 
ISAba125 element provided the -35 sequence of 
the hybrid promoter responsible for the expres-
sion of the bla
NDM-1
 gene [14]. Interestingly, this 
IS element had been originally identiﬁed from 
an A. baumannii isolate (hence its name) without 
any physical association with the bla
NDM
 gene [15]. 
Following this, ISAba125 was identiﬁed in many 
other A. baumannii isolates [6,16]. By contrast, 
this IS has been identiﬁed in Enterobacteriaceae 
and P. aeruginosa only as a remnant of the Tn125 
originating from Acinetobacter species and has 
never been identiﬁed alone in these species [17]. 
This observation suggests that A. baumannii is 
a likely reservoir of ISAba125.
While the f irst studies dealt with the 
bla
NDM
-like genes from enterobacterial iso-
lates, many A. baumannii isolates carrying 
the bla
NDM
-like gene have been now identiﬁed 
(Table 1) [2,18]. The possible progenitor (still not 
identiﬁed) of the bla
NDM
 gene is considered to 
be phylogenetically distant from A. bauman-
nii owing to the guanine-cytosine content of 
this gene (62% for the bla
NDM
 gene vs from 38 
[Acinetobacter calcoaceticus] up to 42% [Acineto-
bacter lwofﬁi] for genomes of Acinetobacter spe-
cies). Likewise, the guanine-cytosine content of 
ISAba125 is 37% and the fact that ISAba125 has 
been identiﬁed alone (not associated with the 
bla
NDM-1 
gene) seems to indicate the occurence 
of independent acquisition of bla
NDM-1
 and 
ISAba125. Transfer of the bla
NDM-1 
gene to 
A. baumannii is probably the result of a transfer 
from an unknown bacterial species to A. bau-
mannii, with both donor and recipient probably 
being present concomitantly in a same environ-
ment. In A. baumannii, the bla
NDM-1 
gene is part 
of a 10,099-bp composite transposon made of 
two copies of ISAba125 (Figure 1) [19]. Down-
stream of bla
NDM-1
/bla
NDM-2
, eight open read-
ing frames have been identiﬁed (Figure 1). The 
ﬁrst corresponds to the ble
MBL
 gene, encoding a 
121-amino acid-long protein conferring resist-
ance to bleomycin (anticancer/antibiotic drug), 
previously found associated with bla
NDM-1 
in 
enterobacterial isolates [20]. Then, several genes 
encoding putative proteins sharing similarities 
with genes identiﬁed from the Brevundimonas 
and Xanthomonas genera were identiﬁed [19]. 
Downstream, two genes encoding the GroES 
and GroEL chaperonin proteins, respectively, 
were identiﬁed. Finally, a gene encoding the 
putative transposase of an IS common region 
(ISCR)-like element was identiﬁed sharing 93% 
protein sequence identity with ISCR19 [21]. ISCR 
elements are IS able to mobilize DNA fragment 
located at their left-hand extremity by rolling-
circle transposition [22]. At the right-hand 
extremity of ISCR21 and before the second 
copy of ISAba125 of Tn125, a truncated gene 
encoding a putative phospholipid acetyltrans-
ferase was identiﬁed, with the corresponding 
protein sequence sharing 91% amino acid iden-
tity with that of Acinetobacter junii (Figure 1) [19]. 
This ﬁnding indicates a likely intermediate state 
that may have occurred in an Acinetobacter spe-
cies other than A. baumannii. Our hypothesis is 
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that an Acinetobacter species acquired the bla
NDM
 
gene from an environmental species, probably 
via a natural transformation process (a physi-
ological process encoded by a wide range of bac-
teria, permitting the uptake of exogneous DNA 
via the binding of dsDNA on a speciﬁc mem-
brane receptor followed by the entry of ssDNA; 
ﬁnally, homologous recombination is necessary 
to incorporate the exogeneous DNA) (Figure 2). 
In that species, the transposon Tn125 was built. 
Subsequently, A. baumannii acquired the bla
NDM
 
gene through the acquisition of this transpo-
son. After its dissemination among Acinetobac-
ter species, an interspecies transfer via a broad-
host range plasmid permitted the acquisition of 
Tn125 by Enterobacteriaceae or P. aeruginosa. 
This step was followed by a large dissemination 
of the bla
NDM
 in Enterobacteriaceae (Figure 2).
Interestingly, a recent study suggested that the 
bla
NDM-1
 has been constructed in Acinetobacter [23]. 
Precise genetic analysis of the blaNDM-1 gene 
itself revealed an interesting feature. It shared the 
5´  end sequence of the aminoglycoside resistance 
gene aphA6 (displaying 100% identity in the spacer 
sequence [260 bp] between ISAba125 and either 
the bla
NDM-1
 or aphA6 genes and the ﬁrst 20 nucleo-
tides of the both genes) [23]. Figure 1B demonstrates 
the two hypotheses of the construction of the 
bla
NDM-1
 into Acinetobacter species:
 Ɣ The ﬁrst hypothesis is a homologous recom-
bination process between, on the one hand, a 
composite transposon made of two copies of 
ISAba125 and carrying the aphA6 gene, and, 
Table 1. Epidemiologic features of NDM-producing Acinetobacter species.
Isolates or species Isolates (n) Acquired 
carbapenemase
Worldwide 
clone
MLST 
analysis†
Country of 
isolation
Probable 
origin
Ref.
Acinetobacter baumannii isolates
A. baumanii JH 1 NDM-1, OXA-23 WWI ST1p Switzerland Balkans 
region
[18]
A. baumannii 
ANC4097
1 NDM-1, OXA-23 WWI ST1p Czech Republic Egypt [40]
A. baumannii 161/07 1 NDM-1 None ST25P Germany Serbia [41]
A. baumannii Slo 1 NDM-1 None ST25P Slovenia Balkans 
region
[18]
A. baumannii 8 NDM-1 None ST85P France North Africa [32]
A. baumannii 
Ab11314
1 NDM-1 WWII ST92B Belgium Algeria [42]
A. baumannii A28, 
A32 and A36
3 NDM-1, OXA-23 N/A N/A India India [26]
A. baumannii 1 NDM-1, OXA-23 N/A N/A Japan India [43]
A. baumannii 
ABCA207, ABC3229, 
ABC4289, ABWA7
4 NDM-1 N/A N/A China China [27]
A. baumannii ML 1 NDM-2 None ST103P Germany Egypt [33]
A. baumannii I1, I2, 
I15, I16, I17
5 NDM-2 None ST103P Israel ? [34]
A. baumannii 124, 
132
2 NDM-2 None ST103P United Arab 
Emirates
United Arab 
Emirates
[35]
Acinetobacter non-baumannii isolates
A. lwoffii WJ10621 1 NDM-1 N/A N/A China ? [44]
A. pittii D499 1 NDM-1 N/A N/A China ? [45]
A. junii 1454 1 NDM-1 N/A N/A China ? [46]
Acinetobacter spp. 9 NDM-1 N/A N/A China China [28]
A. lwoffii SGC-HZ9 1 NDM-1 N/A N/A China China [29]
A. pittii 27 NDM-1 N/A ST63P China China [47]
A. johnsonii 2 NDM-1 N/A N/A China China [30]
†Two diﬀerent MLST schemes are currently available for the typing of Acinetobacter species. Here, STP designed Pasteur’s Institute MLST scheme and STB designed Bartual and 
colleagues MLST scheme. 
MLST: Multilocus sequence typing; N/A: Not applicable; NDM: New Delhi metallo-β-lactamase; OXA: Oxacillinase, class D E-lactamase; ST: Sequence type; WWI: Worldwide clonal 
lineage I; WWII: Worldwide clonal lineage II.
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on the other hand, the bla
NDM-1
 gene, giving 
rise to the neoformed bla
NDM-1
 gene identiﬁed 
in the Tn125;
 Ɣ The construction was due to two steps of the 
rolling-circle transposition event, which 
inserted the fragment containing the bla
NDM-1 
gene from the progenitor into the aphA6 gene 
(Figure 1B).
In light of these recent ﬁndings, a new role 
for A. baumannii may be considered. Although 
usually considered as a ﬁnal recipient of resist-
ance genes, A. baumannii may transfer them 
to Enterobacteriaceae, and P. aeruginosa after 
a probable acquisition from an environmental 
resistome (Figure 2). To date, the role of A. bau-
mannii as a source of resistance genes for other 
clinically signiﬁcant bacterial species has not 
been underlined. There is only one single report 
of the bla
OXA-23
 gene outside A. baumannii, being 
identiﬁed in Proteus mirabilis, as well as another 
single report of acquisition of the natural cepha-
losporinase bla
ADC
 gene in Oligella urethralis (a 
Gram-negative rod belonging to Moraxellaceae 
[24,25]. However, in these two cases, A. bauman-
nii has played the role of progenitor, whereas it 
played the role of an intermediate reservoir for 
the bla
NDM
 genes.
Epidemiology of NDM-producing 
Acinetobacter species
NDM-1-producing A. baumannii were first 
identiﬁed in India [26] and then in China [27]. 
NDM-1-producing non-baumannii Acineto-
bacter, including A. lwofﬁi, A. junii, Acineto-
bacter pittii, Acinetobacter haemolyticus and Aci-
netobacter genomospecies 10 and 15, have been 
reported from nosocomial settings and environ-
mental sources in China [28–30]. In these studies, 
the bla
NDM-1 
gene is carried by a plasmid with a 
size ranging from approximately 30 to 55 kb, 
which may be transferred to E. coli by conju-
gation. Although these experiments are in vitro 
analyses, we might hypothesize that the dissemi-
nation of the bla
NDM
 genes from Acinetobacter 
species to Enterobacteriaceae could be due to the 
interspecies transfer of this plasmid. In contrast 
to what is observed in China, a report highlight-
ing the scattered diffusion of NDM-1-producing 
A. baumannii in Europe demonstrated that this 
dissemination was neither due to a single clone 
nor to plasmid diffusion, but rather to a spread 
of different clones carrying a same transposon 
Tn125 [18]. Multilocus sequence typing (MLST) 
analysis using Pasteur’s Institute scheme [31] 
revealed that the clones circulating in Europe 
belonged to sequence type (ST)1 (also named 
worldwide clone I) and ST25 with a probable 
link with the Balkans region. Recently, several 
A. baumannii clinical isolates possessing the 
bla
NDM-1 
gene and belonging to ST85 accord-
ing to Pasteur’s Institute MLST scheme have 
been identiﬁed. These isolates were recovered 
from patients originating from North Africa, 
with no obvious link to the Indian subconti-
nent. This ﬁnding strongly suggests that a single 
NDM-producing A. baumannii clone is likely 
widespread in North Africa and that it may act 
as a secondary reservoir of spread of the NDM-1 
resistance trait [32]. These genome comparison 
analyses indicated that several reservoirs of 
NDM-1-producing A. baumannii have been 
established at least in Asia (China and India), 
the Balkans region and North Africa.
Hitherto, only a single NDM-1 variant has 
been described in A. baumannii, NDM-2 [33]. 
This variant has been identiﬁed in a German 
patient (with a travel history in Egypt), from 
Israel and from the United Arab Emirates [33–35]. 
MLST analysis revealed that these isolates belong 
to the same clone, ST103 (or ST253 according 
to MLST scheme developed by Bartual and 
Figure 1. Diversity of genetic structures surrounding the blaNDM-1 gene (facing page). (A) Genetic analysis comparison of the 
structures identified in Acinetobacter baumannii and other Gram-negative rods: Tn125 (Genbank accession number JN872329) from 
A. baumannii NRZ [19], pKP-NDM (Genbank accession number JN157804) from Klebsiella pneumoniae Kp7 [48], pNDM-GUE (Genbank 
accession number JQ364967) from Escherichia coli GUE [17] and p271A (Genbank accession number JF785549) from E. coli 271 [14]. Gene 
name abbreviations are deduced from their corresponding proteins. Insertion sequence elements are ISAba125, ISCR21, ISKpn7, IS26, 
ISEC33 and ISSen4, whereas transposon is Tn5403. aadA2 and drfA17 encode aminoglycoside and trimethoprim resistance, respectively. 
Base pair duplications are indicated by 3 and 8 bp. The oriIS of ISCR21 is indicated by a circle. The conserved blaNDM-1 locus is indicated 
by vertical black lines. (B) Possible hypotheses of the blaNDM-1 construction: hypothesis 1: the blaNDM-1 gene could have been constructed 
by a recombination event removing the sequence between the arrows, including the aphA6 gene, and giving rise to the blaNDM-1 gene; 
hypothesis 2: the blaNDM-1 could have been constructed by rolling-circle transposition mediated by ISCR21 into the aphA6 gene. The 
yellow box into the blaNDM-1 gene indicates the shared sequence between the blaNDM-1 and the aphA6 genes. 
IRR: Inverted repeat right; IRL: Inverted repeat left; IS: Insertion sequence; ISCR: Insertion sequence common region.
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iso
iso
iso
ISrmtC
pNDM-KN, Klebsiella pneumoniae, IncA/C, 162,746 bp, JN157804
tat
 
Kpn7
IS
pGUE-NDM, Escherichia coli, IncFII, 87,021 bp, JQ364967 
Δtat
Δtat
IS26 IS26
ISCR1
iso tat dct groES groEL ISCR21
oriIS
iso tat dct groES groEL ISCR21
iso tat dct groES groEL ISCR21
Progenitor
Acinetobacter spp.
A. baumannii
+
terISterIS-like
ISAba125
IRL IRR
Transposition of TnaphA6
near the blaNDM locus 
Homologous recombination
ISAba125 ISAba125
ISAba125
iso tat dct groES groEL ISCR21
IRL IRR
Δpac
iso tat dct groES groEL ISCR21
IRL IRR
∆pac
Hypothesis 1
Hypothesis 2 Rolling-circle transposition
Rolling-circle transposition
+
3´CS
blaNDM
blaNDM
blaNDM
blaNDM
blaNDM
blaNDM
blaNDM
blaNDM
blaNDM
ISAba125
IRL
IRR
bleMBL
bleMBL
bleMBL
bleMBL
bleMBL
bleMBL
bleMBL
bleMBL
bleMBL
tat dct groES groEL ISCR21
ΔISCR21
ISAba125
IRL
IRR
Δpac
oriIS
64% 69%
62%
32% 37%
terIS
3 bp
 
Tn125, Acinetobacter baumannii, chromosomal, 10,099 bp, JN872329 
p271A, E. coli, IncN2, 35,947 bp, JF785549  
isoISEC33 ISSen4
8 bp 8 bp
Tn5403res tnpA
dct groES groEL
terIS
aadA2 dfrA17 intI1
tnpA
3 bp
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colleagues [36]), corresponding to a new clone 
with no link to sequence types found elsewhere. 
In contrast to NDM-1-producing A. baumannii, 
the reservoir of the bla
NDM-2 
gene seems to be 
present at least in the Middle East.
Medical implications
Identiﬁcation of A. baumannii as a source of 
multidrug resistance is now well established. We 
suggest that identiﬁcation of resistance genes in 
A. baumannii worldwide is important, not only 
for preventing the spread of multidrug resistance 
traits in A. baumannii, but also for preventing 
their potential transfer to Enterobacteriaceae, 
which are by far the most important sources 
of infection in humans. A. baumannii, which 
had been mostly considered a weak pathogen 
responsible for infections in immunocompro-
mized patients, may become a Trojan horse for 
spreading antibiotic resistance genes in unre-
lated and clinically signiﬁcant Gram-negative 
species.
More speciﬁcally, identiﬁcation of NDM 
prod ucers in A. baumannii appears to be 
crucial considering that these isolates have 
already disseminated at least in some areas 
(North Africa, Europe, China and India). 
Another important concern is that A. bau-
mannii is well-known to persist much longer 
than Enterobacteriaceae in the environ-
ment [37]. Consequently, outbreaks involving 
multidrug-resistant A. baumannii are difﬁcult 
to eradicate [1,2,38], as exempliﬁed by a study 
demonstrating the re-emergence of the same 
A. baumannii clone 6 months later in a burns 
unit owing to environmental contamination 
[39]. The closure of this burns unit was neces-
sary to eradicate the contamination [39]. Early 
identiﬁcation is therefore very important.
Future perspective
The current diffusion of carbapenemase genes 
in Gram-negative rods is now a serious public 
health issue and, in the near future, could lead 
back to the preantibiotic era. The screening 
of multidrug-resistant A. baumannii and the 
monitoring, in particular, of the carbapenem 
resistance in that species has to be consid-
ered a crucial issue. The NDM saga demon-
strates that the diffusion of the bla
NDM-1
 gene 
in Enterobacteriaceae, probably originating 
from Acinetobacter species, shows that diffu-
sion of resistance genes is more complex than 
expected.
Acquisition of the
blaNDM gene
Transfer of the
blaNDM gene
Wide plasma-mediated
diffusion of the blaNDM genes
(Likely via a natural
transformation process)
(Likely via a transposition process
onto broad-spectrum plasmids)
Likely chromosome located Chromosome or
plasmid located
Mainly plasmid located
Progenitor Intermediate reservoirs Final reservoir
Unknown Firstly Actineobacter species
and then A. baumannii
$#e
$Pseudomonas aeruginosa
$
  Gram-negative rods

various species
Figure 2. Hypothesis of the diffusion of the blaNDM genes from the progenitor to clinical isolates. The different species are 
indicated by different colors.
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EXECUTIVE SUMMARY
Background
 Ɣ Members of the genus Acinetobacter have the ability to rapidly develop resistance to new antibiotics.
 Ɣ The main problem concerning antibiotic resistance in Acinetobacter baumannii corresponds to the rise of carbapenem 
resistance, which is always associated with multidrug resistance.
 Ɣ A. baumannii has been considered as a final recipient of antibiotic resistance genes originating from other clinically 
relevant Gram-negative species.
Carbapenem resistance in A. baumannii
 Ɣ Carbapenem-hydrolyzing Ambler class D E-lactamases are the main source of carbapenem resistance in A. baumannii.
 Ɣ The acquisition of most Ambler class B and A carbapenemases has resulted from the integration of foreign DNA in 
A. baumannii from Enterobacteriaceae or Pseudomonas aeruginosa.
The case of the blaNDM genes
 Ɣ The blaNDM genes are associated with the insertion sequence Aba125 (often truncated in Enterobacteriaceae), which 
plays a role in blaNDM expression. 
 Ɣ In A. baumannii, the blaNDM-1 gene is part of a 10,099-bp composite transposon made of two copies of ISAba125.
 Ɣ A new role may be played by A. baumannii involving the acquisition of the blaNDM-1 resistance gene and then 
transferring it to Enterobacteriaceae and P. aeruginosa.
Epidemiology of NDM-producing Acinetobacter species
 Ɣ NDM-1-producing A. baumannii has been widely identified in India and China from nosocomial settings and 
environmental sources.
 Ɣ Whereas the diffusion of NDM-1-producing A. baumannii in Asia seems to be due to a plasmid diffusion, in 
Europe, it was neither due to a single clone nor any plasmid diffusion, but rather to different clones carrying the 
transposon Tn125.
 Ɣ Multilocus sequence typing analyses indicated several reservoirs of NDM-1-producing A. baumannii including Asia 
(mainly China and India), the Balkans region and North Africa.
Medical implication
 Ɣ The identification of resistance genes in A. baumannii worldwide is important not only for preventing the spread of 
multidrug resistance in A. baumannii, but also for preventing their extension to Enterobacteriaceae.
 Ɣ Outbreaks involving multidrug-resistant A. baumannii are known to be very difficult to eradicate owing to the ability of 
this bacterial species to persist in a nosocomial environment.
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